10x Genomics TXG
$51.80 −$5.58 (-9.72%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $51.01 -1.53%
Open$55.77
Prev close$57.38
Day range$51.30 – $56.44
Volume3.23M
Market cap$6.81B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$150.67M+1.1% YoY
Operating profit-$16.06M+50.2% YoY
Net profit-$19.43M+29.3% YoY
Diluted EPS-$0.15+31.8% YoY
Free cash flow$14.86M-65.1% YoY
Operating cash flow$15.83M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin71.9%
Operating margin-12.2%
Net margin-10.8%
Return on equity-8.3%
Return on assets-6.4%
Return on invested capital-9.0%
Current ratio5.12
Liabilities / assets21.2%
Cash & investments$575.68M
Total debt$63.85M
Net cash (debt)$511.83M
Free cash flow / sales15.2%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $150.67M | $151.04M | $150.84M | $642.82M | $166.03M |
| Total Operating Revenue | $150.67M | $151.04M | $150.84M | $642.82M | $166.03M |
| Cost of Revenue | $37.74M | $38.54M | $44.67M | $198.94M | $52.99M |
| Gross Profit | $112.93M | $112.50M | $106.18M | $443.88M | $113.05M |
| Operating Expense | $128.98M | $135.45M | $123.22M | $554.77M | $132.59M |
| Selling and Admin Expenses | $76.06M | $78.66M | $66.38M | $316.13M | $76.62M |
| Research & Development | $52.93M | $56.79M | $56.85M | $238.63M | $55.97M |
| Operating Profit | -$16.06M | -$22.96M | -$17.05M | -$110.89M | -$19.54M |
| Net Non-Operating Interest Income (Expense) | $5.02M | $4.80M | $5.01M | $20.05M | $6.89M |
| Non-Operating Interest Income | $5.02M | $4.80M | $5.01M | $20.05M | $6.89M |
| Non-Operating Interest Expense | $0.00 | $0.00 | – | $0.00 | $0.00 |
| Other Income (Expense) | -$7.44M | -$487,000.00 | -$815,000.00 | $50.93M | -$2.54M |
| Special Income (Charges) | $0.00 | $3.40M | $0.00 | $49.90M | $0.00 |
| Other Non-Operating Income (Expenses) | -$7.44M | -$3.89M | -$815,000.00 | $1.03M | -$2.54M |
| Pretax Profit | -$18.48M | -$18.65M | -$12.85M | -$39.91M | -$15.19M |
| Tax | $949,000.00 | -$714,000.00 | $623,000.00 | $3.64M | $1.06M |
| Net Profit | -$19.43M | -$17.93M | -$13.47M | -$43.54M | -$16.25M |
| Profit from Continuing Operations | -$19.43M | -$17.93M | -$13.47M | -$43.54M | -$16.25M |
| Net Income to Parent Company | -$19.43M | -$17.93M | -$13.47M | -$43.54M | -$16.25M |
| Net Income to Common Stockholders | -$19.43M | -$17.93M | -$13.47M | -$43.54M | -$16.25M |
| Basic EPS | -$0.15 | -$0.14 | -$0.10 | -$0.35 | -$0.13 |
| Diluted EPS | -$0.15 | -$0.14 | -$0.10 | -$0.35 | -$0.13 |
| -Less:Other Special Charges | – | -$3.40M | – | -$49.90M | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.06B | $1.03B | $1.02B | $1.04B | $1.04B |
| Total Current Assets | $718.63M | $674.67M | $669.73M | $684.45M | $684.45M |
| Cash and Cash Equivalents & Short-Term Investments | $575.68M | $552.03M | $539.85M | $523.41M | $523.41M |
| -Cash and Cash Equivalents | $526.19M | $502.51M | $490.29M | $473.97M | $473.97M |
| -Short Term Investments | $49.49M | $49.52M | $49.56M | $49.44M | $49.44M |
| Receivables | $58.76M | $50.63M | $56.14M | $82.49M | $82.49M |
| -Accounts Receivable | $55.70M | $47.55M | $39.03M | $47.01M | $47.01M |
| -Other Receivables | $3.06M | $3.08M | $17.11M | $35.48M | $35.48M |
| Inventory | $64.63M | $52.62M | $53.49M | $56.34M | $56.34M |
| Other Current Assets | $19.57M | $19.39M | $20.26M | $22.21M | $22.21M |
| Total Non-Current Assets | $344.50M | $355.40M | $346.03M | $356.91M | $356.91M |
| Net PPE | $265.00M | $272.01M | $278.98M | $287.16M | $287.16M |
| -Gross PPE | $439.76M | $439.77M | $439.93M | $440.63M | $440.63M |
| -Accumulated Depreciation | -$174.76M | -$167.76M | -$160.95M | -$153.46M | -$153.46M |
| Goodwill and Other Intangible Assets | $65.58M | $68.08M | $64.42M | $66.84M | $66.84M |
| -Goodwill | $6.92M | $6.92M | $4.51M | $4.51M | $4.51M |
| -Other Intangible Assets | $58.66M | $61.16M | $59.91M | $62.33M | $62.33M |
| Other Non-Current Assets | $13.92M | $15.31M | $2.62M | $2.91M | $2.91M |
| Total Liabilities | $225.09M | $204.52M | $201.44M | $245.04M | $245.04M |
| Total Current Liabilities | $140.37M | $118.51M | $113.60M | $153.45M | $153.45M |
| Payables | $32.07M | $30.22M | $27.77M | $25.49M | $25.49M |
| -Accounts Payable | $21.59M | $20.69M | $17.43M | $12.73M | $12.73M |
| -Total Tax Payable | $6.98M | $6.95M | $6.52M | $7.22M | $7.22M |
| -Other Payable | $3.50M | $2.58M | $3.82M | $5.54M | $5.54M |
| Current Accrued Expenses | $21.59M | $16.01M | $18.87M | $19.81M | $19.81M |
| Short-Term Debt and Capital Lease Obligation | $11.95M | $12.02M | $11.33M | $10.99M | $10.99M |
| -Current Capital Lease Obligation | $11.95M | $12.02M | $11.33M | $10.99M | $10.99M |
| Current Deferred Liabilities | $22.96M | $23.61M | $24.34M | $23.90M | $23.90M |
| Other Current Liabilities | $23.61M | $18.07M | $19.44M | $41.06M | $41.06M |
| Total Non-Current Liabilities | $84.72M | $86.01M | $87.84M | $91.59M | $91.59M |
| Long Term Debt and Capital Lease Obligation | $63.85M | $66.78M | $70.06M | $73.38M | $73.38M |
| -Long Term Capital Lease Obligation | $63.85M | $66.78M | $70.06M | $73.38M | $73.38M |
| Non-Current Deferred Liabilities | $8.53M | $9.68M | $10.14M | $10.50M | $10.50M |
| Other Non-Current Liabilities | $12.35M | $9.55M | $7.64M | $7.71M | $7.71M |
| Total Equity | $838.04M | $825.55M | $814.32M | $796.33M | $796.33M |
| Stockholders' Equity | $838.04M | $825.55M | $814.32M | $796.33M | $796.33M |
| Capital Stock | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -Common Stock | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.40B | $2.37B | $2.34B | $2.31B | $2.31B |
| Retained Earnings | -$1.56B | -$1.54B | -$1.52B | -$1.51B | -$1.51B |
| Gains/Losses Not Affecting Retained Earnings | $197,000.00 | $77,000.00 | $114,000.00 | $225,000.00 | $225,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $15.83M | $16.97M | $26.12M | $136.05M | $40.78M |
| Net cash flow from continuing operations | $15.83M | $16.97M | $26.12M | $136.05M | $40.78M |
| Net Income from Continuing Operations | -$19.43M | -$17.93M | -$13.47M | -$43.54M | -$16.25M |
| Depreciation & Depletion & Amortization | $11.61M | $11.68M | $11.91M | $43.82M | $12.10M |
| Deferred Tax | $0.00 | – | – | – | – |
| Other Non-Cash Items | $7.47M | $3.10M | -$250,000.00 | -$346,000.00 | -$121,000.00 |
| Change in Working Capital | -$6.92M | -$4.06M | $5.29M | $24.94M | $18.58M |
| -Change in Receivables | -$8.12M | $5.50M | $26.11M | $6.44M | $14.10M |
| -Change in Inventory | -$12.21M | $3.00M | $2.70M | $27.95M | $5.58M |
| -Change in Prepaid Assets | -$1.18M | $1.21M | $1.95M | -$2.34M | -$2.99M |
| -Change in Payables and Accrued Expense | $2.65M | -$268,000.00 | -$1.97M | -$7.28M | -$632,000.00 |
| -Change in Other Current Assets | $2.08M | -$12.21M | $282,000.00 | $689,000.00 | -$1.60M |
| -Change in Other Current Liabilities | -$3.26M | -$2.83M | -$2.90M | -$8.91M | -$2.65M |
| -Change In Other Working Capital | $13.13M | $1.54M | -$20.88M | $8.39M | $6.76M |
| Net cash flow from investing | -$503,000.00 | -$7.74M | -$1.31M | -$13.44M | -$1.81M |
| Net Cash Flow from Continuing Investing Activities | -$503,000.00 | -$7.74M | -$1.31M | -$13.44M | -$1.81M |
| Net PPE Purchase and Sale | -$971,000.00 | -$1.59M | -$1.60M | -$5.94M | -$1.78M |
| Net Business Purchase and Sale | $0.00 | – | – | – | – |
| Net Investment Purchase and Sale | $468,000.00 | $454,000.00 | $286,000.00 | $1.77M | $624,000.00 |
| Financing Cash Flow | $8.53M | $3.02M | -$8.42M | $6.80M | $2.24M |
| Net Cash Flow from Continuing Financing Activities | $8.53M | $3.02M | -$8.42M | $6.80M | $2.24M |
| Proceeds from Stock Option Exercised | $8.53M | $3.02M | $273,000.00 | $6.80M | $2.24M |
| Net Other Financing Charges | $0.00 | $0.00 | -$8.69M | – | – |
| Ending Cash Balance | $526.19M | $502.51M | $490.29M | $473.97M | $473.97M |
| Net Change in Cash | $23.86M | $12.26M | $16.39M | $129.42M | $41.21M |
| Beginning Cash Balance | $502.51M | $490.29M | $473.97M | $344.07M | $432.71M |
| Effect of Exchange Rate Changes | -$181,000.00 | -$28,000.00 | -$73,000.00 | $484,000.00 | $43,000.00 |
| Free Cash Flow | $14.86M | $15.39M | $24.52M | $130.12M | $39.00M |
| Net Intangibles Purchase and Sale | – | – | – | $0.00 | $0.00 |
| Net Other Investing Changes | – | – | – | -$9.27M | -$652,000.00 |
No comments yet — be the first to weigh in on TXG.
Sign in to join the discussion.